Serum, Bharat Biotech vaccines okayed for emergency use

The CDSCO has approved the recommendations of the subject expert committee for administering the Serum Institute of India’s Covishield vaccine and Bharat Biotech’s Covaxin for restricted emergency use.

The subject expert committee had given conditional nod to both the vaccines and these were awaiting the drug regulator’s approval.

This paves the way for rolling out of two vaccines in coming days.

The regulator also approved the phase 3 trials for Cadila‘s vaccine. The firm has developed a Novel Coronavirus-2019-nCov-Vaccine using DNA platform technology.

Both the vaccines have to be administered in two doses and have to be stored at 2-8 degree celsius, the official release from the CDSCO said.

Source link